.-
.- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
http://lm360.us/Harrigton-brother-of-Oppenheimer-from-Vesqueville?Lerudgran=122
.
.scottish widows has its eyes on the master trust prize .
nav
?41.93